RxDoctor Payments Data

Thomas Stinnett, MD

Psychiatry · Little Rock, ARNPI 1164568598

Payments from drug & device makers

$1,402in general payments, 2019–2025

Across 116 payments — averaging $12.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$651
  • Otsuka America Pharmaceutical, Inc.$192
  • Alkermes, Inc.$107
  • Takeda Pharmaceuticals U.S.A., Inc.$91
  • Johnson & Johnson$86
  • Teva Pharmaceuticals USA, Inc.$58
  • plus $216 from 9 others

What the payments were for

  • Food & beverage$1,402100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,402 in reported general payments places this provider in the 70th percentile of 235 psychiatry providers in Arkansas.

See all psychiatry providers in Arkansas

Medicare billing

Part B allowed, 2024
$54,037
Medicare patients
123
Services billed
839

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole35$51,018
VraylarCariprazine Hcl23$32,013
TrintellixVortioxetine Hydrobromide18$8,185
Lurasidone Hcl22$5,906
Lisdexamfetamine Dimesylate13$3,267
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine84$2,426
Clozapine19$1,940
Vilazodone Hcl27$1,781
Aripiprazole61$1,743
Oxcarbazepine30$1,231
Alprazolam162$1,032
Desipramine Hcl12$1,027
Bupropion XlBupropion Hcl102$995
Quetiapine Fumarate ErQuetiapine Fumarate24$829
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine22$796

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$192$51,01835 claims
AbbVieVraylar, Synthroid$651$32,57536 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$91$8,18518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 235 psychiatry providers in Arkansas.

Other psychiatry in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →